Tau and Ab imaging, CSF measures, and cognition in Alzheimer's disease

Science Translational Medicine

Volumn 8, Issue 338, 2016, Pages

  Brier, Matthew R ^a   Gordon, Brian ^a,b   Friedrichsen, Karl ^b   McCarthy, John ^c   Stern, Ari ^c   Christensen, Jon ^b   Owen, Christopher ^b   Aldea, Patricia ^b   Su, Yi ^b   Hassenstab, Jason ^a   Cairns, Nigel J ^a   Holtzman, David M ^a   Fagan, Anne M ^a   Morris, John C ^a   Benzinger, Tammie L S ^a,b   Ances, Beau M ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETAPIR F 18; TAU PROTEIN; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SCANNER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE; BRAIN; CEREBROSPINAL FLUID; CLINICAL TRIAL; COGNITION; DIAGNOSTIC IMAGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; COGNITION; FEMALE; HUMANS; MALE; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; TAU PROTEINS;

EID: 84969172281     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf2362     Document Type: Article

References (51)

1. K. Blennow, M. J. de Leon, H. Zetterberg, Alzheimers disease. Lancet 368, 387-403 (2006).
2. H. Braak, E. Braak, Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259 (1991).
3. D. R. Thal, U. Röb, M. Orantes, H. Braak, Phases of Ab-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800 (2002).
4. W. E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D. P. Holt, M. Bergström, I. Savitcheva, G.-F. Huang, S. Estrada, B. Ausén, M. L. Debnath, J. Barletta, J. C. Price, J. Sandell, B. J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C. A. Mathis, B. Langström, Imaging brain amyloid in Alzheimers disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306-319 (2004).
5. M. A.Mintun, G. N. LaRossa, Y. I. Sheline, C. S. Dence, S. Y. Lee, R. H. Mach, W. E. Klunk, C. A. Mathis, S. T. DeKosky, J. C. Morris, [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452 (2006).
6. V. L. Villemagne, M. T. Fodero-Tavoletti, C. L. Masters, C. C. Rowe, Tau imaging: Early progress and future directions. Lancet Neurol. 14, 114-124 (2015).
7. J. A. Hardy, G. A. Higgins, Alzheimers disease: The amyloid cascade hypothesis. Science 256, 184-185 (1992).
8. C. R. Jack Jr., D. S. Knopman, W. J. Jagust, R. C. Petersen, M. W. Weiner, P. S. Aisen, L. M. Shaw, P. Vemuri, H. J. Wiste, S. D. Weigand, T. G. Lesnick, V. S. Pankratz, M. C. Donohue, J. Q. Trojanowski, Tracking pathophysiological processes in Alzheimers disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207-216 (2013).
9. R. J. Bateman, C. Xiong, T. L. S. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling, S. Salloway, J. C. Morris; Dominantly Inherited Alzheimer Network, Clinical and biomarker changes in dominantly inherited Alzheimers disease. N. Engl. J. Med. 367, 795-804 (2012).
10. R. J. Perrin, A. M. Fagan, D. M. Holtzman, Multimodal techniques for diagnosis and prognosis of Alzheimers disease. Nature 461, 916-922 (2009).
11. E. S. Musiek, D. M. Holtzman, Three dimensions of the amyloid hypothesis: Time, space and wingmen. Nat. Neurosci. 18, 800-806 (2015).
12. P. Giannakopoulos, F. R. Herrmann, T. Bussière, C. Bouras, E. Kövari, D. P. Perl, J. H. Morrison, G. Gold, P. R. Hof, Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimers disease. Neurology 60, 1495-1500 (2003).
13. T. Gómez-Isla, J. L. Price, D. W. McKeel Jr., J. C. Morris, J. H. Growdon, B. T. Hyman, Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimers disease. J. Neurosci. 16, 4491-4500 (1996).
14. M. Ingelsson, H. Fukumoto, K. L. Newell, J. H. Growdon, E. T. Hedley-Whyte, M. P. Frosch, M. S. Albert, B. T. Hyman, M. C. Irizarry, Early Ab accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62, 925-931 (2004).
15. J. C. Morris, J. L. Price, Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimers disease. J. Mol. Neurosci. 17, 101-118 (2001).
16. M. Marquié, M. D. Normandin, C. R. Vanderburg, I. M. Costantino, E. A. Bien, L. G. Rycyna, W. E. Klunk, C. A. Mathis, M. D. Ikonomovic, M. L. Debnath, N. Vasdev, B. C. Dickerson, S. N. Gomperts, J. H. Growdon, K. A. Johnson, M. P. Frosch, B. T. Hyman, T. Gómez-Isla, Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann. Neurol. 78, 787-800 (2015).
17. N. Villain, G. Chételat, B. Grassiot, P. Bourgeat, G. Jones, K. A. Ellis, D. Ames, R. N. Martins, F. Eustache, O. Salvado, C. L. Masters, C. C. Rowe, V. L. Villemagne, Regional dynamics of amyloid-b deposition in healthy elderly, mild cognitive impairment and Alzheimers disease: A voxelwise PiB-PET longitudinal study. Brain 135, 2126-2139 (2012).
18. H. Hampel, K. Börger, S. J. Teipel, A. L. W. Bokde, H. Zetterberg, K. Blennow, Core candidate neurochemical and imaging biomarkers of Alzheimers disease. Alzheimers Dement. 4, 38-48 (2008).
19. J. C. Morris, The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414 (1993).
20. D. T. Chien, S. Bahri, A. K. Szardenings, J. C. Walsh, F. Mu, M.-Y. Su, W. R. Shankle, A. Elizarov, H. C. Kolb, Early clinical PET imaging results with the novel PHF-Tau radioligand [F-18]-T807. J. Alzheimers Dis. 34, 457-468 (2013).
21. Y. Su, G. M. DAngelo, A. G. Vlassenko, G. Zhou, A. Z. Snyder, D. S. Marcus, T. M. Blazey, J. J. Christensen, S. Vora, J. C. Morris, M. A. Mintun, T. L. S. Benzinger, Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLOS One 8, e73377 (2013).
22. Y. Su, T. M. Blazey, A. Z. Snyder, M. E. Raichle, D. S. Marcus, B. M. Ances, R. J. Bateman, N. J. Cairns, P. Aldea, L. Cash, J. J. Christensen, K. Friedrichsen, R. C. Hornbeck, A. M. Farrar, C. J. Owen, R. Mayeux, A. M. Brickman, W. Klunk, J. C. Price, P. M. Thompson, B. Ghetti, A. J. Saykin, R. A. Sperling, K. A. Johnson, P. R. Schofield, V. Buckles, J. C. Morris, T. L. S. Benzinger, Dominantly Inherited Alzheimer Network, Partial volume correction in quantitative amyloid imaging. Neuroimage 107, 55-64 (2015).
23. R. A. Sperling, P. S. Aisen, L. A. Beckett, D. A. Bennett, S. Craft, A. M. Fagan, T. Iwatsubo, C. R. Jack Jr., J. Kaye, T. J. Montine, D. C. Park, E. M. Reiman, C. C. Rowe, E. Siemers, Y. Stern, K. Yaffe, M. C. Carrillo, B. Thies, M. Morrison-Bogorad, M. V. Wagster, C. H. Phelps, Toward defining the preclinical stages of Alzheimers disease: Recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 7, 280-292 (2011).
24. C. R. Jack Jr., D. S. Knopman, S. D. Weigand, H. J. Wiste, P. Vemuri, V. Lowe, K. Kantarci, J. L. Gunter, M. L. Senjem, R. J. Ivnik, R. O. Roberts, W. A. Rocca, B. F. Boeve, R. C. Petersen, An operational approach to National Institute on Aging-Alzheimers Association criteria for preclinical Alzheimer disease. Ann. Neurol. 71, 765-775 (2012).
25. R. Lockhart, J. Taylor, R. J. Tibshirani, R. Tibshirani, A significance test for the lasso. Ann. Stat. 42, 413-468 (2014).
26. R. Tibshirani, Regression shrinkage and selection via the lasso. J. Roy. Stat. Soc. B Met. 58, 267-288 (1996).
27. H. Zou, T. Hastie, Regularization and variable selection via the elastic net. J. Roy. Stat. Soc. B 67, 301-320 (2005).
28. G. W. Small, V. Kepe, L. M. Ercoli, P. Siddarth, S. Y. Bookheimer, K. J. Miller, H. Lavretsky, A. C. Burggren, G. M. Cole, H. V. Vinters, P. M. Thompson, S.-C. Huang, N. Satyamurthy, M. E. Phelps, J. R. Barrio, PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 355, 2652-2663 (2006).
29. J. Shin, S.-Y. Lee, S.-H. Kim, Y.-B. Kim, S.-J. Cho, Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimers disease. Neuroimage 43, 236-244 (2008).
30. C.-F. Xia, J. Arteaga, G. Chen, U. Gangadharmath, L. F. Gomez, D. Kasi, C. Lam, Q. Liang, C. Liu, V. P. Mocharla, F. Mu, A. Sinha, H. Su, A. K. Szardenings, J. C. Walsh, E. Wang, C. Yu, W. Zhang, T. Zhao, H. C. Kolb, [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimers disease. Alzheimers Dement. 9, 666-676 (2013).
31. M. T. Fodero-Tavoletti, N. Okamura, S. Furumoto, R. S. Mulligan, A. R. Connor, C. A. McLean, D. Cao, A. Rigopoulos, G. A. Cartwright, G. OKeefe, S. Gong, P. A. Adlard, K. J. Barnham, C. C. Rowe, C. L. Masters, Y. Kudo, R. Cappai, K. Yanai, V. L. Villemagne, 18F-THK523: A novel in vivo tau imaging ligand for Alzheimers disease. Brain 134, 1089-1100 (2011).
32. D. T. Chien, A. K. Szardenings, S. Bahri, J. C. Walsh, F. Mu, C. Xia, W. R. Shankle, A. J. Lerner, M.-Y. Su, A. Elizarov, H. C. Kolb, Early clinical PET imaging results with the novel PHF-Tau radioligand [F18]-T808. J. Alzheimers Dis. 38, 171-184 (2014).
33. M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, B. Ji, J. Maeda, M.-R. Zhang, J. Q. Trojanowski, V. M.-Y. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Q. Chang, T. C. Saido, A. Takashima, J. Lewis, M.-K. Jang, I. Aoki, H. Ito, M. Higuchi, Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79, 1094-1108 (2013).
34. N. Okamura, S. Furumoto, M. T. Fodero-Tavoletti, R. S. Mulligan, R. Harada, P. Yates, S. Pejoska, Y. Kudo, C. L. Masters, K. Yanai, C. C. Rowe, V. L. Villemagne, Non-invasive assessment of Alzheimers disease neurofibrillary pathology using 18F-THK5105 PET. Brain 137 (Pt. 6), 1762-1771 (2014).
35. V. L. Villemagne, S. Furumoto, M. T. Fodero-Tavoletti, R. S.Mulligan, J. Hodges, R. Harada, P. Yates, O. Piguet, S. Pejoska, V. Doré, K. Yanai, C. L. Masters, Y. Kudo, C. C. Rowe, N. Okamura, In vivo evaluation of a novel tau imaging tracer for Alzheimers disease. Eur. J. Nucl. Med. Mol. Imaging 41, 816-826 (2014).
36. K. J. Friston, C. D. Frith, P. F. Liddle, R. S. J. Frackowiak, Functional connectivity: The principal-component analysis of large (PET) data sets. J. Cereb. Blood Flow Metab. 13, 5-14 (1993).
37. J. Hardy, K. Duff, K. G. Hardy, J. Perez-Tur, M. Hutton, Genetic dissection of Alzheimers disease and related dementias: Amyloid and its relationship to tau. Nat. Neurosci. 1, 355-358 (1998).
38. L. K. Clinton, M. Blurton-Jones, K. Myczek, J. Q. Trojanowski, F. M. LaFerla, Synergistic Interactions between Ab, tau, and a-synuclein: Acceleration of neuropathology and cognitive decline. J. Neurosci. 30, 7281-7289 (2010).
39. A. M. Fagan, D. M. Holtzman, Cerebrospinal fluid biomarkers of Alzheimers disease. Biomark. Med. 4, 51-63 (2010).
40. L. F. Maia, S. A. Kaeser, J. Reichwald, M. Hruscha, P. Martus, M. Staufenbiel, M. Jucker, Changes in amyloid-b and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci. Transl. Med. 5, 194re2 (2013).
41. D. K. Johnson, M. Storandt, J. C. Morris, J. E. Galvin, Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch. Neurol. 66, 1254-1259 (2009).
42. E. Grober, H. Buschke, H. Crystal, S. Bang, R. Dresner, Screening for dementia by memory testing. Neurology 38, 900-903 (1988).
43. E. H. Rubin, M. Storandt, J. P. Miller, D. A. Kinscherf, E. A. Grant, J. C. Morris, L. Berg, A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch. Neurol. 55, 395-401 (1998).
44. D. Wechsler, WMS-R: Wechsler Memory Scale-Revised Manual (Harcourt Brace Jovanovich, San Antonio, TX, 1987).
45. J. E. Doppelt, W. L. Wallace, Standardization of the Wechsler adult intelligence scale for older persons. J. Abnorm. Psychol. 51, 312-330 (1955).
46. H. Goodglass, E. Kaplan, The Assessment of Aphasia and Related Disorders (Lea & Febiger, Philadelphia, PA, 1983).
47. S. G. Armitage, An analysis of certain psychological tests used for the evaluation of brain injury, in Psychological Monographs: General and Applied (American Psychological Association, Washington, DC, 1946).
48. A. M. Fagan, M. A. Mintun, R. H. Mach, S.-Y. Lee, C. S. Dence, A. R. Shah, G. N. LaRossa, M. L. Spinner, W. E. Klunk, C. A. Mathis, S. T. DeKosky, J. C. Morris, D. M. Holtzman, Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Ab42 in humans. Ann. Neurol. 59, 512-519 (2006).
49. R. Tarawneh, G. DAngelo, E. Macy, C. Xiong, D. Carter, N. J. Cairns, A. M. Fagan, D. Head, M. A. Mintun, J. H. Ladenson, J.-M. Lee, J. C. Morris, D. M. Holtzman, Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease. Ann. Neurol. 70, 274-285 (2011).
50. G. G. Roussas, A First Course inMathematical Statistics (Addison-Wesley Pub. Co., Reading, MA, 1973).
51. C. E. Weatherburn, A First Course in Mathematical Statistics (The Cambridge Univ. Press, Cambridge, MA, 1946).